Old Web
English
Sign In
Acemap
>
authorDetail
>
Tatiana Scherz
Tatiana Scherz
Actelion
Medicine
Ponesimod
in patient
orally active
Family medicine
5
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Tolerability of Ponesimod Compared to Teriflunomide in Patients with Relapsing Multiple Sclerosis: Results of the Randomized, Active-Controlled, Double-Blind, Parallel-Group Phase 3 OPTIMUM Study (1770)
2020
Neurology
Till Sprenger
Michel Burcklen
Mark S. Freedman
Robert J. Fox
Eva Havrdova
Brian Hennessy
Reinhard Hohlfeld
Fred D. Lublin
Xavier Montalban
Carlo Pozzilli
Andrea Vaclavkova
Tatiana Scherz
Philippe Linscheid
Magdalena Pirozek-Lawniczek
Hilke Kracker
Ludwig Kappos
Show All
Source
Cite
Save
Citations (0)
Long-term Efficacy and Safety of Ponesimod, an oral S1P1 Receptor Modulator: Results from Randomized Phase II Core and Extension Studies in Relapsing-Remitting Multiple Sclerosis (1752)
2020
Neurology
Mark S. Freedman
Carlo Pozzilli
Eva Havrdova
Patricia K. Coyle
Alexandre Lemle
Michel Burcklen
Anna Larbalestier
Brian Hennessy
Tatiana Scherz
Andrea Vaclavkova
Tomas Olsson
Show All
Source
Cite
Save
Citations (2)
1